ValiRx ValiRx ValiTherma ValiMedix
ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Annual Reports
Live Quote
 
 
Aim Rule 26 Admission Document Advisors and Bankers Annual Reports Constitutional Document Corporate Governance General Meeting Documentation Shareholders Information Shares in Issue Stock Information  

Please click on the links below to view the attachments:

ValiRx Plc - Interim Results For The Six Months Ended 30 June 2011

ValiRx Plc - Report & Accounts For The Year Ended 31 December 2010

ValiRx Plc - Interim Results For The Six Months Ended 30 June 2010

ValiRx Plc - Report and Accounts for the period ended 31 December 2009

ValiRx Plc - Interim results for the six months ended 30 June 2009     

ValiRx Plc - Report and Accounts for the period ended 31 December 2008 

ValiRx Plc -Interim results for the six months ended 30 June 2008     

ValiRx Plc - Accounts Summary for the period ended 31 December 2007     

ValiRx Plc - Interim results for the six months ended 30 June 2007    

ValiRx Plc - Report and Accounts for the period ended 31 Dec 2007     

ValiRx Plc - Accounts for the period ended 31 December 2006